For US Healthcare Professionals
I am a:
IN ADULTS WITH ACTIVE PSORIATIC ARTHRITIS (PsA)
~9 out of 10 PsA patients continued therapy through 2 years* in DISCOVER 2 and prior to Week 48 in DISCOVER 11
No conclusions regarding clinical efficacy or safety can be drawn.
*Year 2 represents Week 100.
†Discontinuations shown for patients who were randomized and received at least 1 study drug administration.
‡1 patients-initiated protocol-prohibited medication in the placebo group through Week 24.
Reference: 1. Data on file. Janssen Biotech, Inc.
IN ADULTS WITH MODERATE TO SEVERE PLAQUE PsO
